Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer
出版年份 2016 全文链接
标题
Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 28, Pages 7750-7755
出版商
Proceedings of the National Academy of Sciences
发表日期
2016-06-26
DOI
10.1073/pnas.1605841113
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
- (2015) Xi Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
- (2015) Miles A. Miller et al. Science Translational Medicine
- High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with 99mTc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin
- (2014) Oscar Arrieta et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Fluorescent Semiconducting Polymer Dots for Biology and Medicine
- (2013) Changfeng Wu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- Image-guided cancer surgery using near-infrared fluorescence
- (2013) Alexander L. Vahrmeijer et al. Nature Reviews Clinical Oncology
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
- (2012) Robert C. Smallridge et al. THYROID
- Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
- (2012) Panayiotis Savvides et al. THYROID
- Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives
- (2011) Ki Young Choi et al. Nanoscale
- The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
- (2010) Ranit Kedmi et al. BIOMATERIALS
- B-RafV600E and thrombospondin-1 promote thyroid cancer progression
- (2010) C. Nucera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Endocytosis
- (2009) Gary J. Doherty et al. Annual Review of Biochemistry
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- A Novel Orthotopic Mouse Model of Human Anaplastic Thyroid Carcinoma
- (2009) Carmelo Nucera et al. THYROID
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started